ViaCyte, Inc. to Present at Upcoming Stem Cell Meeting on the Mesa Conference

These two presentations will highlight this first-in-human testing and several other recent developments. ViaCyte's VC-01 product candidate consists of pancreatic progenitor cells, called PEC-01 cells, derived from a proprietary human stem cell line, encapsulated in ViaCyte's proprietary Encaptra device.

http://ift.tt/1s3bSBz